Sodium Hydroxide → HCID 24989243, compound
Reaction equation
[Br:1][C:2]1[CH:30]=[CH:29][C:28]([F:31])=[CH:27][C:3]=1[O:4][CH:5]1[CH2:10][CH2:9][N:8]([C:11]2[N:15]=[C:14]([C:16]3[CH:20]=[CH:19][N:18]([CH2:21][C:22]([O:24]CC)=[O:23])[N:17]=3)[O:13][N:12]=2)[CH2:7][CH2:6]1.[OH-].[Na+]>>[Br:1][C:2]1[CH:30]=[CH:29][C:28]([F:31])=[CH:27][C:3]=1[O:4][CH:5]1[CH2:10][CH2:9][N:8]([C:11]2[N:15]=[C:14]([C:16]3[CH:20]=[CH:19][N:18]([CH2:21][C:22]([OH:24])=[O:23])[N:17]=3)[O:13][N:12]=2)[CH2:7][CH2:6]1Participants
3
Procedure
The title compound was prepared in a similar manner as described in Example 7 (step 5) from ethyl (3-{3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)acetate and aqueous NaOH. 1H NMR (500 MHz, acetone-d6): δ7.97 (s, 1H), 7.62 (t, 1H), 7.12 (d, 1H), 6.94 (s, 1H), 6.75 (s, 1H), 5.22 (s, 2H), 4.91 (s, 1H), 3.82-3.75 (m, 2H), 3.63-3.57 (m, 2H), 2.16-2.07 (m, 2H), 1.94 (s, 2H). MS: m/z 466, 468 (MH+).
Sources & evidence
- ORD record
- ord-b5443fbc98194d2ab2333ffccf91eb4e
- Source dataset
- uspto-grants-2011_11
- Patent number
- US08063224B2
Reaction notes
Loading…